AQA
PFE icon

Alpha Quant Advisors’s Pfizer PFE Stock Holding History

Alpha Quant Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$770K Sell
19,100
-2,594
-12% -$104K 0.77% 57
2018
Q4 		$898K Buy
+21,694
New +$901K 0.93% 51

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alpha Quant Advisors's PFE Position: Q1 2019 in Review

Alpha Quant Advisors reduced its Pfizer (PFE) stake by 12% in Q1 2019, selling an estimated $104K and leaving 19,100 shares worth $770K. The position accounts for 0.77% of the portfolio, ranked #57.

Alpha Quant Advisors first reported a position in PFE in Q4 2018 and has held it in 2 quarters since. The position peaked at $898K in Q4 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Alpha Quant Advisors held 19,100 shares of Pfizer worth $770K as of Q1 2019.
  • Alpha Quant Advisors sold 2,594 Pfizer shares in Q1 2019, an estimated $104K.
  • Pfizer made up 0.77% of Alpha Quant Advisors's portfolio in Q1 2019, its #57 holding.
  • Alpha Quant Advisors first reported a position in Pfizer in Q4 2018 and has held it in 2 quarters since.
  • Alpha Quant Advisors's Pfizer position peaked at $898K in Q4 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.